Mainz Biomed (MYNZ) Return on Sales (2022 - 2023)
Historic Return on Sales for Mainz Biomed (MYNZ) over the last 4 years, with Q2 2025 value amounting to 24.14%.
- Mainz Biomed's Return on Sales rose 64400.0% to 24.14% in Q2 2025 from the same period last year, while for Jun 2025 it was 24.14%, marking a year-over-year increase of 64400.0%. This contributed to the annual value of 24.22% for FY2024, which is 51500.0% up from last year.
- Latest data reveals that Mainz Biomed reported Return on Sales of 24.14% as of Q2 2025, which was up 64400.0% from 28.97% recorded in Q4 2024.
- Over the past 5 years, Mainz Biomed's Return on Sales peaked at 24.14% during Q4 2023, and registered a low of 57.82% during Q3 2022.
- In the last 4 years, Mainz Biomed's Return on Sales had a median value of 33.15% in 2023 and averaged 37.11%.
- In the last 5 years, Mainz Biomed's Return on Sales skyrocketed by 300900bps in 2023 and then tumbled by -48300bps in 2024.
- Mainz Biomed's Return on Sales (Quarter) stood at 42.37% in 2022, then skyrocketed by 43bps to 24.14% in 2023, then dropped by -20bps to 28.97% in 2024, then rose by 17bps to 24.14% in 2025.
- Its Return on Sales was 24.14% in Q2 2025, compared to 28.97% in Q4 2024 and 30.58% in Q2 2024.